MedCrypt welcomes Ken Hoyme to the advisory board

Hoyme brings Boston Scientific, Adventium Labs and Honeywell experience to proactive medical device cybersecurity provider

SAN DIEGO, July 6, 2022 /PRNewswire/ — MedCrypt Inc.the leading provider of proactive security solutions for the healthcare industry, today announced the addition of Ken Home to its advisory board. Ken brings 40 years of experience in the design of secure regulated and safety-critical systems as well as his knowledge of medical device safety and regulation. In this role, Ken will advise MedCrypt’s strategy and support the company on its path to continued growth as a leading provider of medical device cybersecurity solutions.

“Having seen the importance of safety in healthcare and the rapid changes within the industry throughout my career, I am thrilled to join an organization that I firmly believe is at the cutting edge of medical device safety, operating with a high level of excellence and ethics,” said Ken Home, former senior product safety researcher for Boston Scientific. “The great work I’ve seen from MedCrypt will truly drive change in the industry and I look forward to working with an organization that is pushing for software that will secure critical medical devices.”

Ken recently retired from Boston Scientific as a Senior Product Security Fellow, where he established the company-wide product security program, integrating security requirements into their quality system. He has been active in many industry initiatives, including:

  • H-ISAC Medical Device Security Information Sharing Council (MDSISC) Co-Chair
  • One of the original co-chairs of the AAMI Device Safety Task Force, which produced AAMI TIR57, a report outlining the principles of medical device safety and risk management
  • Member of the BI&T editorial board of the AAMI
  • A participant in several HSCC JCWG working groups, including the development of the Joint Security Plan
  • Participant and manager of cybersecurity projects with the Medical Device Innovation Consortium (MDIC)
  • One participant at each meeting of the Archimedes Center for Device Health and Safety at University of Michigan
  • Instigator of the creation of the Cybersecurity Center for Medical Devices (CMDC) in University of Minnesotaand co-trainer for their first short courses

“MedCrypt is thrilled to announce the addition of Ken Home to our advisory board. Ken is a true industry pioneer, having served at the forefront of some of the industry’s largest cybersecurity organizations,” said Mike Kijewski, CEO of MedCrypt. “We are excited to get new insights from Ken and benefit from the vast knowledge and innovation he has to offer.”

Previously, Ken was a Scientist Emeritus at Adventium Labs conducting government-funded research on the intersection of safety and security for cyber-physical systems. He won a contract from the Department of Homeland Security (DHS) to develop a medical device platform using separation architectures to simplify the implementation of safety and security controls.

Prior to that, he was a Senior Fellow at Boston Scientific in their Cardiac Rhythm Management division where he led the development of the LATITUDE remote patient management system. This system, released in 2005, incorporates secure protocols between the implant, programmer, home monitor, and web server to maintain security and privacy.

Prior to Boston Scientific, Ken spent 18 years at Honeywell’s Corporate Research Lab, where he was a Senior Fellow. He received Honeywell’s highest technical honor for his work on the Boeing 777. Ken earned 40 US patents and 9 international patents and earned his bachelor’s and master’s degrees in electrical engineering from the University of Minnesota.

“Having Ken Hoyme join our advisory board demonstrates MedCrypt’s continued commitment to providing security-focused cybersecurity solutions to medical device manufacturers. We look forward to his contribution and leadership to support our mission,” added Axel WirthChief Security Strategist of MedCrypt.

Ken joins as an advisor alongside Michael McNeilwhich was added to MedCrypt’s board of directors in 2020. MedCrypt currently provides enhanced security features and services to seven of the top 10 medical device manufacturers as well as startups and midsize companies, particularly for medical products from Accuray, Liberate Medical and Réflexion.

About MedCrypt

MedCrypt is the first company to combine cybersecurity technology products with management consulting, decision science and regulatory strategy that is 100% focused on supporting medical device manufacturers. MedCrypt has garnered more than $9.4 million in funding to date with participation from Eniac Ventures, Section 32, Y Combinator, and more. To learn more, please visit


jenny bourne


About John Tuttle

Check Also

Diabetes drug Ozempic in short supply as many mistakenly take it for weight loss

Semaglutide, a prescription drug, sold primarily under the brand name Ozempic, is prescribed to help …